Core Viewpoint - The company announced the redemption of a structured deposit from Industrial Bank, amounting to 38 million yuan, with a return of 46,100 yuan, and plans to reinvest the same amount into cash management without affecting the progress of fundraising projects or normal operations [1] Group 1 - The company will redeem a structured deposit from Industrial Bank on February 2, 2026, for a total of 38 million yuan [1] - The redemption will yield a profit of 46,100 yuan [1] - The company will reinvest the redeemed amount into cash management using idle fundraising funds [1] Group 2 - The redemption will not impact the progress of fundraising investment projects [1] - The company's normal production and operations will remain unaffected by this financial maneuver [1]

Core Viewpoint - Lisheng Pharmaceutical (002393) has seen a significant increase in stock price, reaching a nearly one-year high, and is actively managing idle funds through short-term financial products [1][2]. Company Stock Performance - As of June 13, 2025, Lisheng Pharmaceutical's stock closed at 22.11 yuan, up 13.79% from the previous week [1]. - The stock reached a peak of 22.11 yuan during the week and a low of 19.5 yuan [1]. - The company's current market capitalization is 5.698 billion yuan, ranking 83rd out of 150 in the chemical pharmaceutical sector and 2608th out of 5150 in the A-share market [1]. Company Announcements - Lisheng Pharmaceutical announced the use of up to 1 billion yuan of idle self-owned funds for cash management, investing in short-term financial products with a maturity of no more than 12 months [2]. - The company has invested 50 million yuan in financial products from Industrial Bank, including 10 million yuan in a flexible income product and 40 million yuan in a stable income product, with expected yields of approximately 2% and 2.2% respectively [2]. - The total amount of idle self-owned funds invested in financial products as of the announcement date is 639 million yuan, which is within the authorized limit [2]. Fund Management - Lisheng Pharmaceutical also plans to use up to 600 million yuan of idle raised funds for cash management, investing in short-term financial products with a maturity of no more than 12 months [2]. - The company has invested 50 million yuan in structured deposits from Industrial Bank, with an expected annual yield of 1.20%-1.80% [2]. - The total amount of idle raised funds invested in financial products as of the announcement date is 85 million yuan, also within the approved limit [2].